The Supplement II to the Intermediary Report



		Chemical Safety Office Evaluation and Licensing Division Pharmaceutical and Food Safety Bureau Ministry of Health, Labor and Welfare

Last updated date: March 30, 2015


Advisory Committee on Health Effects of Endocrine Disruptors The Supplement II to the Intermediary Report Contents March 31, 2005
	Introduction
Chapter 1:	Results of major actions and future tasks
	Section 1:	Test scheme
	Section 2:	Sampling and analysis
	Section 3:	The low-dose issue
	Section 4:	Epidemiology of exposure
	Section 4-1:	Exposure in living organisms
	Section 4-2:	Epidemiologic studies
	Section 5:	Risk communication
Chapter 2:	Summary and action plan
	Action Plan
	Working group members and references
	APPENDIX